Physician profile
Amy D Sharp
NPI 1447428909
$1,358.62
in general payments reported to CMS, 2019-2025
13 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2022: $238 · 2023: $346 · 2024: $238 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.81 |
| Education | $108.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $491.09 | 2021-2025 | |
| Glaxosmithkline, LLC. | $252.58 | 2022-2025 | Nucala |
| Axsome Therapeutics, INC. | $177.41 | 2023-2025 | Sunosi |
| Sanofi-Aventis U.S. LLC | $108.98 | 2024-2025 | |
| Kaleo, INC. | $90.97 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $68.20 | 2021-2025 | Dupixent |
| Inspire Medical Systems, INC. | $51.89 | 2023-2024 | Inspire |
| Genzyme Corporation | $38.48 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $21.05 | 2024 | Voquezna |
| Pfizer INC. | $18.48 | 2023 | |
| Jazz Pharmaceuticals INC. | $15.64 | 2021 | |
| Abbvie INC. | $11.95 | 2021 | |
| Stryker Corporation | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.